# Profil Institut für trials: 26

ClinicalTrials.gov lists 26 trials with Profil Institut für Stoffwechselforschung GmbH as lead sponsor, 1 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Profil Institut für Stoffwechselforschung GmbH: 26 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/profil-institut-f-r-stoffwechselforschung-gmbh

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07913698 | Clinical Research Trial to Study Insulin Sensitivity Using Automated Glucose Clamp Technology | Profil Institut für Stoffwechselforschung GmbH | Observational | Not yet recruiting | Obesity Type 2 Diabetes Mellitus, Obese Adults, Type 2 Diabetes Mellitus | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913698) |
| December 2, 2017 | NCT03359590 | Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients | Profil Institut für Stoffwechselforschung GmbH | Phase 2 | Completed | Pharmacological Action | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03359590) |
| August 21, 2017 | NCT03254849 | Empagliflozin and Sympathetic Nerve Traffic | Profil Institut für Stoffwechselforschung GmbH | Phase 4 | Completed | Type 2 Diabetes Mellitus | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03254849) |
| August 10, 2015 | NCT02518581 | Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus | Profil Institut für Stoffwechselforschung GmbH | Not applicable | Completed | Diabetes | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02518581) |
| March 30, 2015 | NCT02401880 | Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology | Profil Institut für Stoffwechselforschung GmbH | Phase 4 | Completed | Type 2 Diabetes Mellitus | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02401880) |
| September 4, 2014 | NCT02231658 | Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Terminated | Diabetes Mellitus | 109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02231658) |
| August 20, 2014 | NCT02221323 | A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1 | Profil Institut für Stoffwechselforschung GmbH | Phase 2 | Completed | Diabetes Mellitus | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02221323) |
| February 7, 2014 | NCT02057497 | An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms | Profil Institut für Stoffwechselforschung GmbH | Observational | Withdrawn | Prediabetes, Diabetes Type 1, Diabetes Type 2 | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02057497) |
| September 9, 2013 | NCT01937702 | A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Diabetes Mellitus | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01937702) |
| September 5, 2013 | NCT01936025 | A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2... | Profil Institut für Stoffwechselforschung GmbH | Phase 2 | Completed | Type 2 Diabetes Mellitus | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01936025) |
| August 5, 2013 | NCT01916265 | Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Diabetes Mellitus Type 1 | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01916265) |
| July 29, 2013 | NCT01910194 | Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying | Profil Institut für Stoffwechselforschung GmbH | Phase 2 | Completed | Diabetes Mellitus | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01910194) |
| July 29, 2013 | NCT01910051 | Explorative Assessment of Biomarkers in Overweight and Obese Subjects | Profil Institut für Stoffwechselforschung GmbH | Observational | Completed | Prediabetes | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01910051) |
| July 24, 2013 | NCT01906970 | Clinical Experimental Study to Investigate Specific Features of ClampArt® | Profil Institut für Stoffwechselforschung GmbH | Not applicable | Completed | Diabetes Mellitus | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01906970) |
| July 19, 2013 | NCT01903070 | Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment | Profil Institut für Stoffwechselforschung GmbH | Phase 4 | Completed | Diabetes Mellitus | 99 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01903070) |
| November 21, 2012 | NCT01730885 | A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes | Profil Institut für Stoffwechselforschung GmbH | Phase 4 | Completed | Diabetes Mellitus | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01730885) |
| October 20, 2011 | NCT01456026 | Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes | Profil Institut für Stoffwechselforschung GmbH | Not applicable | Completed | Type 2 Diabetes Mellitus | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01456026) |
| September 28, 2011 | NCT01441986 | Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects | Profil Institut für Stoffwechselforschung GmbH | Phase 2 | Completed | Type 2 Diabetes Mellitus | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01441986) |
| June 3, 2010 | NCT01135771 | Performance Study Using the OptiScanner on Healthy Diabetics | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Diabetes | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01135771) |
| February 2, 2010 | NCT01060917 | Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring Device | Profil Institut für Stoffwechselforschung GmbH | Phase 1/2 | Completed | Diabetes Mellitus | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01060917) |
| January 28, 2010 | NCT01058577 | Changes in Serum Electrolytes at Different Glucose Concentrations + Impact on a Non-invasive Glucose Monitoring Method | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Diabetes Mellitus | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01058577) |
| September 23, 2009 | NCT00982254 | Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Type 2 Diabetes | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00982254) |
| September 10, 2009 | NCT00974740 | DIATOR-Diabetes Intervention With Atorvastatin | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Terminated | Type 1 Diabetes | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00974740) |
| September 4, 2009 | NCT00971659 | Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Type 2 Diabetes | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00971659) |
| September 1, 2009 | NCT00969592 | Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers | Profil Institut für Stoffwechselforschung GmbH | Phase 1 | Completed | Diabetes | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00969592) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 10 |
| Phase 1/2 | 1 |
| Phase 2 | 5 |
| Phase 4 | 4 |
| Not applicable | 3 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus | 15 |
| Diabetes Mellitus, Type 2 | 9 |
| Diabetes Mellitus, Type 1 | 3 |
| Prediabetic State | 2 |
| Hypoglycemia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dominican restaurants in the United States](https://specstream.ai/data/businesses/dominican-restaurants/united-states)
- [Home insurance agencies in the United States](https://specstream.ai/data/businesses/home-insurance-agencies/united-states)
- [Moving companies in the United States](https://specstream.ai/data/businesses/moving-companies/united-states)
- [Roofing contractors in the United States](https://specstream.ai/data/businesses/roofing-contractors/united-states)
- [Water softening equipment suppliers in the United States](https://specstream.ai/data/businesses/water-softening-equipment-suppliers/united-states)
- [Blinds and shades companies in the United States](https://specstream.ai/data/businesses/blinds-and-shades-companies/united-states)
